About us

Our goal is to be able to prescribe medicinal cannabis and cannabis products or preparations with a therapeutically effective content of tetrahydrocannabinol or other cannabinoids within the scope of a medically justifiable need.

The need for further training on this topic is particularly great as the number of patients continues to rise. With our symposium we want to create the basic conditions to be able to offer necessary and qualitatively valuable medical education. Medical Cannabinoids Conference The purpose of the Medical Cannabinoids Conference is to provide physicians and healthcare professionals with an opportunity to better understand the therapeutic uses of cannabinoids and the current state of knowledge in research.

The Austrian Society for Addiction Medicine (AUSAM) deals with the research focus on alcohol dependence, tobacco dependence and organic mental disorders. The Austrian Society for Addiction Medicine aims to improve the medical and social situation of addicted patients and has been warning for many decades about the consequences of alcohol and tobacco dependence.

Univ. Prof. Dr. Leschspecialist in retired psychiatry and psychotherapy, President of the Österr. Society for Addiction Medicine (AUSAM) and Board of Directors Member of the International Academy of Law and Mental Health (IALMH), specializes in medical and sociological aspects of use, abuse and dependency - especially of alcohol and tobacco. He has also been involved in international health policy for many years and is the author of numerous scientific contributions.

In 2009 veröffentlichte er einen Ein Leitfaden für die Erkennung und Behandlung von Alkohol- und Tabak-Missbrauch und kritisiert den oft viel zu lockeren Umgang mit dem Thema “Sucht”.

Cannabis is to be treated by law like tobacco, alcohol and sedatives. Cannabis sativa is not a luxury food, but contains pharmacologically active substances that belong in the hands of a professional, ie doctor or pharmacist.